Skip to main content

Table 4 A brief list of CTL Epitopes to form the final structure of the vaccine

From: Development of a novel multi‑epitope vaccine against the pathogenic human polyomavirus V6/7 using reverse vaccinology

specie

epitopes

protein

C-score

Immunogenicity score

antigenicity

allergenicity

toxicity

epitope conservancy

hit (maximum identity %)

human homology

interacting MHC-I alleles

HPyV6

LSHATLGNK

LTAg

1.2320

0.10205

1.5211

probable

non-allergen

non-toxic

100

non-homologue

HLA-A*11:01, HLA-A*03:01, HLA-A*30:01

FERWVSFGM

LTAg

1.3474

0.24276

1.2787

probable

non-allergen

non-toxic

100

non-homologue

HLA-B*18:01, HLA-B*40:01, HLA-B*40:02

WLLFVLEEL

VP2

1.1038

0.28696

0.7654

probable

non-allergen

non-toxic

100

non-homologue

HLA-A*02:01, HLA-A*02:06

IYKVEAILL

VP1

1.5128

0.21171

0.4174

probable

non-allergen

non-toxic

100

non-homologue

HLA-A*24:02, HLA-B*35:03

HPyV7

MELTDVLLI

LTAg

1.2565

0.08008

1.3253

probable

non-allergen

non-toxic

100

non-homologue

HLA-B*44:02, HLA-B*44:03, HLA-B*40:01, HLA-B*18:01, HLA-B*53:01, HLA-B*40:02, HLA-B*51:01

TPKRRNLLF

LTAg

1.3998

0.01055

1.7138

probable

non-allergen

non-toxic

100

non-homologue

HLA-B*08:01, HLA-B*07:02

GPRIGSTTM

VP2

 

0.08343

0.7918

probable

non-allergen

non-toxic

100

non-homologue

HLA-B*07:02

LWLPQAWPW

VP2

1.0974

0.08973

0.5232

probable

non-allergen

non-toxic

100

non-homologue

HLA-A*24:02, HLA-B*58:01, HLA-B*57:01, HLA-A*23:01, HLA-B*53:01

DTMIVWEAY

VP1

2.0643

0.43299

0.5828

probable

non-allergen

non-toxic

100

non-homologue

HLA-A*26:01, HLA-A*25:01, HLA-A*01:01, HLA-B*35:01, HLA-B*18:01, HLA-A*29:02, HLA-A*30:02, HLA-B*46:01

TELLFAPQM

VP1

1.0319

0.05903

0.8241

probable

non-allergen

non-toxic

100

non-homologue

HLA-B*18:01, HLA-B*44:02, HLA-B*40:02, HLA-B*44:03, HLA-B*40:01